Skip to main content Skip to section navigation Skip to footer
Careers
Codexis, Inc. Corporate Page
  • About Us
    • Overview
    • Culture
    • Our People
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Sustainability
  • Services
    • Overview
    • Pharmaceutical Biocatalysis
    • RNA Manufacturing
  • Technology
    • CodeEvolver® Platform
    • ECO Synthesis™ Technology
  • Technical Content
  • Newsroom
    • Overview
    • In The News
    • Media Assets
  • Investors
    • Overview
    • News & Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • chevron_leftCareers

Access our TIDES USA 2025 Investor Recap Call

View Replay

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • TIDES US
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • At-a-Glance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Codexis Ethics Helpline
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • TIDES US
Sep 29, 2023 7:05 am EDT
Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
Read More
Sep 18, 2023 4:05 pm EDT
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
Read More
Sep 12, 2023 4:05 pm EDT
Codexis to Participate in Cantor Global Healthcare Conference
Read More
Sep 7, 2023 4:05 pm EDT
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
Read More
Aug 3, 2023 4:05 pm EDT
Codexis Reports Second Quarter 2023 Financial Results
Read More
Jul 31, 2023 4:05 pm EDT
Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics
Read More
Jul 20, 2023 4:05 pm EDT
Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
Read More
Jun 9, 2023 4:05 pm EDT
Codexis Announces New Employment Inducement Grants
Read More
May 24, 2023 4:05 pm EDT
Codexis to Participate in Jefferies Healthcare Conference
Read More
May 10, 2023 4:05 pm EDT
Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
Read More
  • Previous Pagechevron_left
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 26
  • Next Pagechevron_right
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed

Headquarters

200 Penobscot Drive
Redwood City, California
94063

Contact Us

©2025 Codexis, Inc. All Rights Reserved.
  • Sitemap
  • Terms of Sale
  • Trademarks
  • Terms of Use
  • Privacy
  • Accessibility Statement
  • Disclaimer
  • Patents
  • Events
  • Careers